highperformr logo

Mallinckrodt Pharmaceuticals's Overview

Total employees3369
HeadquartersDublin
Founded1867

Mallinckrodt is a global biopharmaceutical company consisting of multiple wholly owned subsidiaries that develop, manufacture, market, and distribute specialty pharmaceutical products and therapies. The company's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; and gastrointestinal products. Following a period of financial restructuring, Mallinckrodt continues to focus on serving patients with severe and critical conditions.

Where is Mallinckrodt Pharmaceuticals's Headquarters?

HQ Function

Serves as the company's global corporate and legal headquarters, overseeing international operations, corporate governance, financial reporting, and housing key administrative functions.

Notable Features:

Located in a modern business park designed to support international pharmaceutical operations and corporate management.

Work Culture:

Emphasizes global collaboration, innovation in pharmaceuticals, adherence to international regulatory standards, and a strong focus on compliance and patient outcomes.

HQ Significance:

Central point for global strategy, financial oversight, and the legal framework of the company. Its location in Ireland supports its international business operations and access to European markets.

Values Reflected in HQ: Global reach, operational efficiency, commitment to compliance, and ethical business practices on an international scale.

Location:

Mallinckrodt supports global operations focusing on the development, manufacturing, and commercialization of specialty branded pharmaceuticals and therapies. This includes research and development activities, clinical trials, regulatory affairs, supply chain management, and marketing and sales across key markets, primarily in North America and Europe, with distribution to other international regions.

Street Address:

College Business & Technology Park, Cruiserath, Blanchardstown

City:

Dublin

State/Province:

Dublin 15

Country:

Ireland

Mallinckrodt Pharmaceuticals's Global Presence

Bedminster, New Jersey, USA

Address: 1425 U.S. Route 206, Bedminster, New Jersey 07921

Primary hub for U.S. operations, strategic decision-making for the North American pharmaceutical market, and coordination of U.S.-based research, development, and commercial activities.

Staines-upon-Thames, Surrey, United Kingdom

Address: First Floor, Block C, The Crescent, Skerne Road, Richmond, Surrey, TW9 2PU

Serves as the legal registered address for the public limited company, supporting corporate governance and UK-specific administrative requirements.

St. Louis, Missouri, USA

Address: Hazelwood or Webster Groves (various facilities in the area)

Key manufacturing and R&D hub, particularly for Mallinckrodt's specialty generics segment and API production, contributing to the company's global supply chain.

Buying Intent Signals for Mallinckrodt Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Mallinckrodt Pharmaceuticals

As of April 2025, Mallinckrodt Pharmaceuticals' leadership includes:

Sigurdur (Siggi) Olafsson - President and Chief Executive Officer
Bryan Reasons - Executive Vice President and Chief Financial Officer
Peter G. Edwards - Executive Vice President and Chief Legal Officer & Company Secretary
Lisa French - Executive Vice President and Chief Commercial Officer, Specialty Brands
Frank Scholz, M.D., Ph.D. - Executive Vice President and Chief Medical and Scientific Officer
Jo-Ann Beltramello - Senior Vice President and Chief Human Resources Officer

Investors of Mallinckrodt Pharmaceuticals

Mallinckrodt Pharmaceuticals has been backed by several prominent investors over the years, including:

Privately held company; primary ownership by a consortium of its former creditors, including various investment management firms and financial institutions, following its emergence from Chapter 11 restructuring in November 2023.

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

Following its emergence from Chapter 11 restructuring in November 2023, Mallinckrodt confirmed its leadership team, including the key appointment of a new Chief Financial Officer. Some executive transitions also occurred during the restructuring period.

Departures

Karen Ling, Karen Ling departed from her role as EVP and Chief Human Resources Officer during the company's restructuring period prior to its emergence from Chapter 11.

New Appointments:

Bryan Reasons, Bryan Reasons was appointed as the new EVP and CFO upon Mallinckrodt's successful emergence from financial restructuring.

Technology (Tech Stack) used by Mallinckrodt Pharmaceuticals

Discover the tools Mallinckrodt Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Mallinckrodt Pharmaceuticals Email Formats and Examples

Mallinckrodt commonly uses the 'first.last' email format for its employees. Variations might exist for very common names or specific departments, but this is the most prevalent structure.

[first].[last]@mallinckrodt.com

Format

jane.doe@mallinckrodt.com

Example

85%

Success rate

News and media

Mallinckrodt Press ReleaseApril 2, 2024

Mallinckrodt Presents New Data on Terlipressin Highlighting Real-World Evidence and Clinical Outcomes in Adults with Hepatorenal Syndrome (HRS) at EASL Congress 2024

Mallinckrodt announced the presentation of new data on Terlipressin, emphasizing its real-world effectiveness and clinical benefits for adults suffering from hepatorenal syndrome, at the upcoming EASL Congress 2024....more

Mallinckrodt Press ReleaseMarch 7, 2024

Mallinckrodt Recognizes Patient Advocacy Organizations on Rare Disease Day 2024

Mallinckrodt highlighted its commitment to patients with rare diseases by acknowledging and supporting various patient advocacy organizations on Rare Disease Day 2024, emphasizing its focus on addressing unmet medical needs....more

PR Newswire (covering Mallinckrodt Press Release)November 15, 2023

Mallinckrodt Successfully Completes Financial Restructuring and Emerges from Chapter 11

Mallinckrodt plc announced it has successfully completed its financial restructuring process and emerged from Chapter 11, strengthening its financial foundation and positioning the company for long-term growth and to continue serving patients....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Mallinckrodt Pharmaceuticals, are just a search away.